J&J forecasts $2.5 bln in COVID-19 vaccine sales this year

Mandeep Sethi 21 Jul 2021 130

J&J reported $164 million in COVID-19 vaccine sales for the second quarter, bringing total sales to $264 millionso far...

July 21 (Reuters) - Johnson & Johnson (JNJ.N) on Wednesday forecast $2.5 billion in sales of its one-shot COVID-19 vaccine this year based on the current price of $5 per dose and said that could rise to $8 a dose by the end of the year.

read more at Reuters

English News

Living in India

Comments

Picture


EXPLORE MORE INTEREST